Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Current Assets of $55.8 million for Q1 2026, up 138.09% year-over-year from $23.4 million in Q1 2025, and up 106.85% quarter-over-quarter from $27.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Current Assets (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Current Assets for 11 consecutive years, with $55.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 138.09% year-over-year to $55.8 million; the TTM figure through Mar 2026 stood at $55.8 million (up 138.09% YoY), while the FY2025 annual figure was $27.0 million, down 13.82% from the prior year.
- Current Assets climbed to $55.8 million in Q1 2026 per SLGL's latest filing, from $27.0 million in the prior quarter.
- Across five years, Current Assets topped out at $55.8 million in Q1 2026 and bottomed at $23.4 million in Q1 2025.
- Historically, Current Assets has averaged $40.1 million across 5 years, with a median of $40.7 million in 2023.
- Annual changes were most pronounced in 2025 — Current Assets tumbled 34.92% — and 2026, when it surged 138.09%.
- Sol-Gel Technologies' Current Assets stood at $43.1 million in 2022, then declined by 4.39% to $41.2 million in 2023, then dropped by 23.98% to $31.3 million in 2024, then retreated by 13.82% to $27.0 million in 2025, then soared by 106.85% to $55.8 million in 2026.
- Business Quant data shows SLGL's Current Assets at $55.8 million in Q1 2026, $27.0 million in Q4 2025, and $31.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 55.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.79 Mn |
| Dec 31, 2025 | 26.97 Mn |
| Sep 30, 2025 | 31.65 Mn |
| Jun 30, 2025 | 36.26 Mn |
| Mar 31, 2025 | 23.43 Mn |
| Dec 31, 2024 | 31.30 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 38.28 Mn |
| Mar 31, 2024 | 36.01 Mn |
| Dec 31, 2023 | 41.17 Mn |
| Sep 30, 2023 | 45.47 Mn |
| Jun 30, 2023 | 51.59 Mn |
| Mar 31, 2023 | 40.68 Mn |
| Dec 31, 2022 | 43.06 Mn |
| Sep 30, 2022 | 47.56 Mn |
| Jun 30, 2022 | 48.48 Mn |
| Mar 31, 2022 | 46.72 Mn |
| Dec 31, 2021 | 57.11 Mn |
| Sep 30, 2021 | 48.15 Mn |
| Jun 30, 2021 | 41.39 Mn |